A unanimous U.S. Senate has voted to expand research into cannabis to see if there are any medical benefits to the drug and its compounds, including cannabidiol.
The Cannabidiol and Marihuana Research Expansion Act also would require the U.S. Department of Health and Human Services and the National Institutes of Health to report to Congress on the potential benefits or harms associated with using cannabis.
The legislation, sponsored by U.S. Sen. Dianne Feinstein, D-Calif., passed Thursday by voice vote.
“Current rules and regulations make it hard for researchers to study how marijuana and marijuana-derived medications can best be used to treat various conditions,” Feinstein said.
It now goes to the House, which in December 2020 voted to expand research into the medicinal properties of cannabis by allowing researchers to obtain samples from states that have legalized weed, rather have the University of Mississippi as the only federally approved source of the drug.
Rep. Earl Blumenauer, D-Ore., co-chair of the Congressional Cannabis Caucus, reintroduced the House bill last October.
Your email address will not be published. Required fields are marked *
Save my name, email, and website in this browser for the next time I comment.
Notify me of follow-up comments by email.
Notify me of new posts by email.
Tyler Williams is the founder and Chief Technical Officer of St. Louis, Missouri-based CSQ, short for Cannabis Safety and Quality. Founded in 2020, the seed-to-sale third-party cannabis certification provider is a subsidiary of ASI Food Safety, which for decades has offered a range of safety and quality audits and certifications in the Food and Beverage,…
The issue isn’t top of mind for most voters, but the Democratic frontrunner is betting that it could help draw people to the polls. LANCASTER, Pa. — Few Senate candidates sell campaign T-shirts emblazoned with marijuana leaves. But head over to Pennsylvania Lt. Gov. John Fetterman’s website, or drop by one of his rallies, and…
The Cannabis Control Board issued its first license on Monday for retail marijuana cultivation in Vermont. Officials say more licenses are in the pipeline but frustration is growing for some who are trying to plant their roots in the industry. Despite a slight delay in the cannabis licensing process, businesses looking to get into the…
By Fred Rocafort, Attorney at Harris Bricken The Drug Enforcement Administration (DEA) issued an interim final rule on hemp (“DEA hemp rule” or “rule”) on August 20, 2020. As per its executive summary, the rule “merely conforms DEA’s regulations to the statutory amendments to the [Controlled Substances Act (CSA)] that have already taken effect, and…